Osteonecrosis of the jaws and bisphosphonates.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Alpha Omegan

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AODF.2007.10.013PMID 18335818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series.

  2007cited by this paper
• Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

  2007cited by this paper
• Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

  2007cited by this paper
• Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.

  2007cited by this paper
• Bisphosphonates: Mode of Action and Pharmacology

  2007cited by this paper
• Possible association between diabetes and bisphosphonate-related jaw osteonecrosis.

  2007cited by this paper
• The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line.

  2007cited by this paper
• Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis

  2007cited by this paper
• Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

  2007cited by this paper
• Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro.

  2007cited by this paper
• Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)].

  2007cited by this paper
• Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single‐centre experience in 303 patients

  2006cited by this paper
• Safety of oral bisphosphonates: controlled studies on alveolar bone.

  2006cited by this paper
• The effect of zoledronic acid on the function and differentiation of myeloid cells.

  2006cited by this paper
• A meta-analysis of six-month studies of antiplaque and antigingivitis agents.

  2006cited by this paper
• Molecular Mechanisms of Action of Bisphosphonates: Current Status

  2006cited by this paper
• Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

  2006cited by this paper
• Update on the Epidemiology of Paget's Disease of Bone

  2006cited by this paper
• Remodeling dynamics in the alveolar process in skeletally mature dogs.

  2006cited by this paper
• Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?

  2006cited by this paper
• Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

  2006cited by this paper
• Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.

  2006cited by this paper
• Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws.

  2006cited by this paper
• Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

  2006cited by this paper
• Bisphosphonate-Associated Osteonecrosis of the Jaw

  2006cited by this paper
• Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.

  2005cited by this paper
• Alveolar bone necrosis and tooth exfoliation following herpes zoster infection: a review of the literature and case report.

  2005cited by this paper
• Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

  2005cited by this paper
• Osteonecrosis of the jaw and bisphosphonates.

  2005cited by this paper
• Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity.

  2004cited by this paper
• Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

  2004cited by this paper
• Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

  2003cited by this paper
• Bisphosphonates and metastatic breast carcinoma

  2003cited by this paper
• A phase 2 study of bortezomib in relapsed, refractory myeloma.

  2003cited by this paper
• Triclosan/pyrophosphate dentifrice: dental plaque and gingivitis effects in a 6-month randomized controlled clinical study.

  2002cited by this paper
• Zoledronic acid reduces skeletal‐related events in patients with osteolytic metastases

  2001cited by this paper
• Alendronate-related oral mucosa ulcerations.

  2000cited by this paper
• Necrosis of the gingiva caused by calcium hydroxide: a case report.

  2000cited by this paper
• Severe Oral Ulcerations Induced by Alendronate

  1999cited by this paper
• Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

  1995cited by this paper
• Lingual mandibular sequestration and ulceration.

  1993cited by this paper
• Osteoradionecrosis: a new concept of its pathophysiology.

  1983cited by this paper

• American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update.

  2022cites this paper
• Considerations about bisphosphonate therapy and patients using dental prosthesis: a literature review

  2021cites this paper
• Green tea extract synergistically enhances the effectiveness of an antiresorptive drug on management of osteoporosis induced by ovariectomy in a rat model

  2021cites this paper
• Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol

  2018cites this paper
• Oral Manifestations of Drug Reactions

  2017cites this paper
• Oral Manifestations of Drug Reactions

  2017cites this paper
• isphosphonate-associated osteonecrosis of the jaws in lung ancer patients

  2017cites this paper
• Chapter 25 Drug-Induced Oral Reactions

  2017cites this paper
• Osteoporosis as it Affects Men, Andropausal and Senior Males

  2017influential citation
• Osteonecrose dos maxilares associada ao uso de bifosfonatos: uma revisão de literatura

  2016cites this paper
• Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology

  2016cites this paper
• Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review

  2016cites this paper
• Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.

  2015cites this paper
• Medication--related osteonecrosis of the jaws. The first reported cases in the Baltic States and a literature review.

  2015cites this paper
• Drug-Induced Oral Reactions

  2015cites this paper
• Influence of bisphosphonates on Implantology – literature review

  2015cites this paper
• “Bisphosphonates: Possible Modes of Action and Implications for Dental Implant Treatment. A Review of the Literature”

  2015cites this paper
• Concomitant Factors Leading to an Atypical Osteonecrosis of the Jaw in a Patient with Multiple Myeloma

  2014cites this paper
• Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months

  2014cites this paper
• MAXILLARY SINUSITIS AFTER BISPHOSPHONATES TREATMENT

  2014cites this paper
• Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw

  2014cites this paper
• Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin?

  2013cites this paper
• Considerações da Implantologia sobre a osteonecrose dos maxilares potencializada pela terapia com bisfosfonatos

  2013cites this paper
• Diagnosis and Treatment of Bone Disease in Multiple Myeloma: Spotlight on Spinal Involvement

  2013cites this paper
• Ninety-One Osteoporosis Patients Affected with Bisphosphonate-Related Osteonecrosis of the Jaw: A Case Series

  2013cites this paper
• [Bisphosphonate-associated osteonecrosis of the jaws in lung cancer patients].

  2013cites this paper
• Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours.

  2013cites this paper
• Bisphosphonates – Risk Assessment of Osteonecrosis of the Jaw and Potential Benefits for Periodontal Therapy

  2012cites this paper
• Factors influencing surgical treatment of bisphosphonate‐related osteonecrosis of the jaws

  2012cites this paper
• Effect of anastrozole on bone mineral density and lipid profiles when used to prevent breast cancer in high risk postmenopausal women

  2012cites this paper
• UPDATE ON OSTEONECROSIS RELATED TO BISPHOSPHONATES: A REPORT OF THREE CLINICAL CASES

  2012cites this paper
• Bisphosphonate-related osteonecrosis of the jaws--a review.

  2012cites this paper
• In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis

  2012cites this paper
• What you need to know about Bisphosphonates: An Overview and General Recommendations for Orthodontic Treatment

  2012cites this paper
• Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female

  2012cites this paper
• What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.

  2012cites this paper
• Bisphosphonates and osteonecrosis of the jaw : a multidisciplinary approach

  2012cites this paper
• Patient-related risk factors for implant therapy. A critique of pertinent literature.

  2011cites this paper
• Clinical Strategies to Address Patients' Concerns in Osteoporosis Management with Bisphosphonates

  2011cites this paper
• Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies

  2011cites this paper
• [Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].

  2011cites this paper
• Bisphosphonate-associated Osteonecrosis of the Jaw in Ontario: A Survey of Oral and Maxillofacial Surgeons

  2011cites this paper
• Current Concepts on the Pathogenesis and Natural History of Steroid-Induced Osteonecrosis

  2011cites this paper
• Osteonecrosis of the jaw and bisphosphonates

  2010cites this paper
• Oral Lesions and Lymphoproliferative Disorders

  2010cites this paper
• Urinary tract infection in primary care How doctors deliver care

  2010cites this paper
• OSTEONECROSE DA MANDÍBULA E/OU MAXILAS EM PACIENTES SUBMETIDOS À TERAPIA COM BISFOSFONATOS

  2010cites this paper
• Ostéonécroses de la mâchoire et bisphosphonates : état des connaissances en 2009

  2009cites this paper
• Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations

  2009cites this paper
• Bisphosphonates and time to osteonecrosis development.

  2009cites this paper
• Analysis of bone activity of jaws using scintigraphy on patients before, during and after treatment with IV bisphosphonates: A retrospective study

  2009cites this paper
• Bisphosphonate Associated Osteonecrosis of the Jaw

  2009cites this paper
• Systemic conditions and treatments as risks for implant therapy.

  2009cites this paper
• Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws.

  2009cites this paper
• American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

  2009cites this paper
• Bisphosphonate‐associated osteonecrosis of the jaws: The limits of a conservative approach

  2009cites this paper
• Social-medical Aspects of Mandible Necrosis Caused by Zolendric Adic

  2009cites this paper
• Osteonecrose dos Maxilares Associada ao Uso de Bisfosfonatos, Revisão da Literatura e Apresentação de um Caso Clínico

  2009cites this paper
• Progress Toward Understanding the Etiology of Otosclerosis and Implications for Future Management

  2009cites this paper
• Opioid rotation: logical choices for pain that is poorly responsive to morphine

  2009cites this paper
• Bisphosphonates and oral surgery

  2009cites this paper
• Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations

  2009cites this paper
• Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

  2008cites this paper
• Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.

  2008cites this paper
• Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.

  2008cites this paper
• Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.

  2008cites this paper
• Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update.

  2008cites this paper
• Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients

  2008influential citation
• Ostéonécroses des maxillaires sous bisphosphonates

  2008cites this paper
• Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.

  2008cites this paper
• Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management

  2008cites this paper
• Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.

  2007cites this paper
• Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review.

  2007cites this paper
• American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.

  2007cites this paper
• Ostéonécroses des maxillaires sous bisphosphonates

  2007cites this paper
• Bisphosphonate-related osteonecrosis of the jaws: a call for multidisciplinary approaches.

  2007cites this paper
• Osteonecrosis de los maxilares asociada al empleo de bifosfonatos Bisphosphonate-associated osteonecrosis of the jaw

  2007cites this paper
• Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases.

  2007influential citation
• Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy

  2007cites this paper
• Use of the International System for Human Cytogenetic Nomenclature (ISCN).

  2006cites this paper
• Response : Increased mortality with FLA compared with ADE

  2006cites this paper
• Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws

  2006cites this paper
• Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role

  2006cites this paper